We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Roche Logo

Roche

Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in vitro diagnostics and a global supplier of transformative, innovative solutions across major disease areas. They are a global pioneer in pharmaceuticals and diagnostics, focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Latest Roche Content

Computer-generated image of cancer cells.
News

Immunotherapy for "Difficult-to-Treat" Lung Cancer Improves Overall Survival for Some Patients

The trial results are good news for non-small cell lung cancer patients who are not eligible for standard-of-care platinum-based chemotherapy.
Digital LightCycler
Product
Advertisement

Digital LightCycler® dPCR System: Unleash the true power of digital PCR

This digital PCR system for DNA and RNA features 6 advanced optical channels for flexible, multiplexed biomarker detection, with advances in sensitivity, precision and flexibility. The Digital LightCycler® System is a powerful digital PCR system that aims to help laboratories push the boundaries of clinical research forward
NGS image with TMi10 logo
Video

An Overview of NGS Adapters for Ligation-based Library Preparation

In this Teach Me in 10 we are joined by senior field application scientist Nick Hapshe.
A primer on NGS Adapters: Structural Elements, Key functions, and Workflow Differences content piece image
eBook

A Primer on NGS Adapters: Structural Elements, Key Functions and Workflow Differences

Unique molecular identifiers (UMIs) now present a solution that can reduce quantitative bias, distinguish between PCR duplicates, and recognize sequencing errors.

A brain and a tumor under the words "Applications of Liquid Biopsy"
Article

Applications of Liquid Biopsy in Cancer and Beyond

Liquid biopsies are becoming an increasingly important tool for the early detection, prognosis and monitoring of treatment outcomes in cancer, and hold the promise of transforming the management of other diseases in the future.

Model of the human heart.
News

Bioprinted Patches Repair Damaged Heart Tissue

A new technology that uses bioprinted patches to repair damaged heart tissue has been proven to be safer and more cost-effective for patients.
The Pistoia Alliance logo
Product News

Pistoia Alliance Launches Pharma Innovation Council and Appoints New Chief Portfolio Officer

The Pistoia Alliance has launched the Pistoia Alliance Pharma Innovation Council. The Council will seed ideas for new pre-competitive projects aligned with the Alliance’s strategic themes: Emerging sciences and Technology, Improving the Efficiency and Effectiveness of R&D and Empowering the Patient.
View of buildings in Basel.
Industry Insight

Basel: Europe’s Booming Biotech Powerhouse

This article spotlights the driving forces behind Basel’s snowballing reputation, and notes some of the success stories arising from this innovative biotech powerhouse.
A globe surrounded by zeroes and ones to represent data
Article

Data Reporting, Integrity and Compliance

In this article, we examine how analytical scientists can enhance their data sharing and reporting practices, leading to improvements in data integrity and an easier route to compliance within a regulated good manufacturing practice (GMP) environment.
Qnovia, Inc. Raises $17 Million in Series A Funding To Advance Its Inhalable Therapeutics Pipeline content piece image
Product News

Qnovia, Inc. Raises $17 Million in Series A Funding To Advance Its Inhalable Therapeutics Pipeline

Qnovia, Inc., a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement therapy and cardiopulmonary diseases, has announced it has raised $17 million in Series A funding.
Advertisement